2007-2020年法国斯特拉斯堡由Kazachstania spp.引起的真菌感染
分析法国斯特拉斯堡大学医院2007-2020年13例由Kazachstania(Arxiozyma)spp.引起的真菌感染病例,其中4例为确诊真菌病(3例侵袭性真菌病和1例皮肤黏膜感染),9例为定植。11例同时分离出白色念珠菌。所有菌株经MALDI-TOF鉴定为K. telluris,3株经ITS测序确认为K. bovina。所有受试菌株对氟康唑的MIC均>2 μg/mL。
要点
- 13例中4例为确诊真菌病,9例为定植,11例同时分离出白色念珠菌。
- 所有菌株经MALDI-TOF鉴定为K. telluris,3株经ITS测序确认为K. bovina。
- 所有受试菌株对氟康唑的MIC均>2 μg/mL。
核心结论
- 罕见真菌病原体正成为侵袭性真菌感染的病原体,Kazachstania spp.感染的出现可能与免疫受损和胃食管疾病患者增多有关。
研究设计与样本
- 对法国斯特拉斯堡大学医院2007-2020年13例由Kazachstania(Arxiozyma)spp.引起的真菌感染病例进行分析。
主要发现
- 13例中4例为确诊真菌病(3例侵袭性真菌病和1例皮肤黏膜感染),9例为定植。
- 13例中11例同时分离出白色念珠菌。
- 确诊侵袭性真菌病的患者均不符合宿主标准,但多数有基础疾病。
- 所有菌株经MALDI-TOF鉴定为K. telluris,3株经ITS测序确认为K. bovina。
- 所有受试菌株对氟康唑的MIC均>2 μg/mL。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rare fungal pathogens are emerging as agents of invasive fungal infections. We analyzed 13 cases of fungal infections caused by Kazachstania (Arxiozyma) spp. in Strasbourg University Hospital, Strasbourg, France. Among the cases, 4 patients had proven fungal disease (3 cases of invasive fungal disease and 1 mucocutaneous infection) and 9 were colonized by Kazachstania (Arxiozyma) spp. Candida albicans was also isolated from 11 of the 13 patients. None of the patients with proven invasive fungal disease met host criteria, but most had underlying diseases. All strains were identified as K. telluris by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and 3 were confirmed as K. bovina by internal transcribed spacer sequencing. For all tested strains, the MICs for fluconazole were >2 μg/mL. Emergence of this rare fungal infection might be explained by the increasing number of patients with immunocompromised conditions and gastroesophageal diseases.
引用
- Kaeuffer C, Baldacini M, Ruge T, et al. Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007-2020. Emerg Infect Dis. 2022. PMID: 34932452. doi:10.3201/eid2801.211543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。